Thrive Earlier Detection
Thrive Earlier Detection Corp. was a healthcare/biotech company commercializing CancerSEEK, a machine-learning-driven liquid biopsy blood test to detect multiple cancer types from a single blood draw. Spun out of Johns Hopkins technology and backed by Lux Capital, Bain Capital Life Sciences, Casdin, Google Ventures and others, it raised large early rounds before being acquired by Exact Sciences in 2020/2021 for roughly $2.15 billion and folded into Exact Sciences. This profile was surfaced as a Lux Capital portfolio company and added to the API Evangelist network as an enrichment lead. It is a clinical-diagnostics company with no public developer API surface; its former web presence (thrivedetect.com) is decommissioned.
Thrive Earlier Detection is profiled on the APIs.io network. Tagged areas include Company, Biotech, Healthcare, Diagnostics, and Cancer Screening.